Webinar Executive Summary
Value added medicines are therapies where innovation has been applied around an off-patent molecule, for example by reformulation or applying a device.
Download the executive summary of the webinar ‘A Patient-Centric Approach to Digital Value Added Medicines’, presented by Aurelio Arias, Engagement Manager, Thought Leadership, IQVIA, and hosted by Generics Bulletin, to learn more about the drivers associated with value added medicine, as well as the challenges and future trends associated with this sector.
- Value added medicines can introduce innovation into primary care worldwide and reduce healthcare costs
- The Value Added Medicines sector is worth $44 billion, approximately the size of France’s total prescription spend.
- Patient centricity generates competitive advantage for drug manufacturers
- The future for value added medicines lies in digital integration.
You can also listen to the recorded webinar by clicking here